StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) stock

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$40.70−0.90 (-2.16%)

Close on Nov 17, 2026Market cap $181.73BP/E 12.0Yield –

Novo Nordisk A S enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Novo Nordisk A S's enterprise value was $199.99B on Nov 11, 2026, against $234.73B a year earlier. Over the last 5 years it ranged from $181.28B to $639.08B, with a median of $316.89B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$199.99B-17.3%
2025Dec 31, 2025$241.71B-37.4%
2024Dec 31, 2024$386.13B-17.4%
2023Dec 29, 2023$467.69B+47.6%
2022Dec 30, 2022$316.89B+20.0%
2021Dec 31, 2021$264.05B+59.0%
2020Dec 31, 2020$166.09B+20.2%
2019Dec 31, 2019$138.13B+23.6%
2018Dec 31, 2018$111.79B-16.0%
2017Dec 29, 2017$133.10B+47.6%
2016Dec 30, 2016$90.19B–

More Novo Nordisk A S figures

See a number that looks wrong?